← Eichor
Study identifier: NCT07627334 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Personalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening: Advanced Brain Tumor TheRApy Clinical Trial In Patients Scheduled for shOrt Course radiatioN

Condition: Glioblastoma (GBM)  ·  Sponsor: Medical University of Vienna

PhaseNA
Planned participants30
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

Patients will receive in addition to standard histology analysis also the PDC- based drug screening.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (1)

AKH Vienna, Department for Internal Medicine I, OncologyVienna, State of Vienna, AustriaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07627334